Hepatoid adenocarcinoma of the stomach – a different histology for not so different gastric adenocarcinoma: a case report
Open Access
- 12 August 2009
- journal article
- Published by Springer Nature in International Seminars in Surgical Oncology
- Vol. 6 (1) , 13
Abstract
Hepatoid adenocarcinoma is an extrahepatic tumor characterized by morphological similarities to hepatocellular carcinoma. Hepatoid adenocarcinoma of the stomach is a cancer with an extremely poor prognosis with few cases reported. Here, we describe a 75-year-old Spanish man referred to our hospital with a history of abdominal pain, general fatigue, anorexia and sickness. Initial study revealed anemia, and computed tomography scan and abdominal ultrasonography showed multiple metastases to the liver with hepatocellular carcinoma characteristics in a liver with no cirrhotic change. Further study included a serum level of alpha-fetoprotein (AFP), which resulted markedly elevated, and a conclusive esophagogastroduodenoscopy describing an elevated tumour growing through the cardia and gastroesophageal junction with foci of necrosis and haemorrhage. Gastric biopsies of the tumor revealed poorly differenciated adenocarcinoma, with hepatoid differentiation. After a diagnosis of AFP-producing hepatoid adenocarcinoma of the stomach with multiple liver metastases was made, pallitive total gastrectomy, without liver resection, was performed. Patient recovered well after surgery, and entered into a palliative systemich chemotherapy protocol. Although this illness is recognized as having poor prognosis, the patient remains alive 8 months after the operation. Accurate diagnosis of hepatoid adenocarcinoma of the stomach is important, and should be suspected under certain circumstances. We describe this rare case of hepatoid adenocarcinoma of the stomach, and review the literature concerning the clinicopathological aspects.Keywords
This publication has 31 references indexed in Scilit:
- Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junctionAnnals of Oncology, 2008
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinomaJournal of Digestive Diseases, 2007
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- PALLIATIVE GASTRECTOMY IN ADVANCED GASTRIC CANCER: IS IT WORTHWHILE?Anz Journal of Surgery, 2006
- Palliative chemotherapy for advanced gastric cancerAnnals of Oncology, 2004
- Surgery for stage IV gastric cancerThe American Journal of Surgery, 2004
- Value of palliative resection in gastric cancerBritish Journal of Surgery, 2002
- Hepatoid adenocarcinoma of the stomachGastric Cancer, 2001
- Primary lung cancer producing α-fetoproteinThe Annals of Thoracic Surgery, 1992